Status:

COMPLETED

Early Detection of Cardiac Impairment and Prediction of RV Hypertrophy in Patients With CTD

Lead Sponsor:

RenJi Hospital

Conditions:

Connective Tissue Diseases

Right Ventricular Hypertrophy

Eligibility:

All Genders

18-80 years

Brief Summary

There have been reports suggesting that progressive RV failure and death in connective tissue disease (CTD) are related to right ventricular hypertrophy (RVH) and dilation, irrespective of pulmonary a...

Detailed Description

Patients with connective tissue disease (CTD) frequently exhibit multi-organ pathophysiological and functional damage. The heart, one of the leading causes of CTD mortality, has attracted increasing a...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for CTD with RVH
  • Age between 18-80 years old.
  • Definite connective tissue diseases diagnosis.
  • Echocardiography demonstration (later confirmed by CMR) of a hypertrophic RV when maximal end-diastole RV wall thickness \>4 mm due to CTD
  • Inclusion Criteria for CTD without RVH
  • Age between 18-80 years old.
  • Definite connective tissue diseases diagnosis.
  • Echocardiography demonstration (later confirmed by CMR) that maximal end-diastole RV wall thickness ≤4 mm
  • Inclusion Criteria for Control group:
  • Absence of known systemic diseases
  • Normal examinations
  • Age between 18-80 years old.
  • Providing written informed consent
  • Exclusion Criteria:
  • Age \<18 years old or \>80 years old
  • Documented coronary artery disease or prior angiography for coronary artery disease (\>50% stenosis).
  • Patients with known congenital heart disease or other systemic diseases that might induce RVH.
  • Patients with standard metallic contraindications to CMR or an estimated glomerular filtration rate \< 30 ml/min/1.73 m2.

Exclusion

    Key Trial Info

    Start Date :

    July 1 2014

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2016

    Estimated Enrollment :

    136 Patients enrolled

    Trial Details

    Trial ID

    NCT04297371

    Start Date

    July 1 2014

    End Date

    November 1 2016

    Last Update

    August 13 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Renji Hospital

    Shanghai, Shanghai Municipality, China, 200127

    Early Detection of Cardiac Impairment and Prediction of RV Hypertrophy in Patients With CTD | DecenTrialz